Seamac India Pharmaceuticals Private Limited

Seamac India Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1994PTC059752 Incorporated 22 June 1994 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Revenue · FY 2024
₹1.42 Cr
▼ 51% YoY
Net profit · FY 2024
₹56,373
Net margin 0.4%
EBITDA · FY 2024
₹8.92 Lakh
EBITDA margin 6.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4.37 Lakh
Issued & subscribed
Open charges
₹52.2 Lakh
Secured borrowings
Company age
32 yrs
Est. 1994
Directors on board
2
As per MCA filings

About Seamac India Pharmaceuticals Private Limited

Data last updated:

Seamac India Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 June 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC059752. Its GSTIN is 02AAACS3400P1ZN (Himachal Pradesh).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.37 Lakh. It is led by directors Sudhir Sharma (Managing Director) and Abhishek Sharma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 3 Lgf Lajpat Nagar, New Delhi, Delhi, India – 110024.

As per the financials filed for FY 2024, the company reported a revenue of ₹1.42 Cr, a decline of 51% compared to the previous year. For the same year it recorded a net profit of ₹56,373 (net margin 0.4%) and EBITDA of ₹8.92 Lakh (EBITDA margin 6.3%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 15% over five years.

As per MCA filings, the company has open charges of ₹52.2 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74899DL1994PTC059752
Registration Number 059752
Incorporation Date 22 June 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Seamac India Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    D – 3 Lgf Lajpat Nagar, New Delhi, Delhi, India – 110024
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Seamac India Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Seamac India Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Seamac India Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Seamac India Pharmaceuticals Private Limited, buy the company report.

Financials of Seamac India Pharmaceuticals Private Limited

FY 2025 filings available

Seamac India Pharmaceuticals Private Limited reported revenue of ₹1.42 Cr (down 51% YoY) for FY 2024.

Revenue · FY 2024
₹1.42 Cr ▼ 51%
Net profit · FY 2024
₹56,373 margin 0.4%
EBITDA · FY 2024
₹8.92 Lakh margin 6.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 51%
3 years · compounded
▼ 18%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 1%
5 years · compounded
▲ 1%

Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 51% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹8.92 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹56,373
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin6.3%
Net Profit Margin0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Seamac India Pharmaceuticals Private Limited, buy the company report.

Board of directors of Seamac India Pharmaceuticals Private Limited

Seamac India Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Sudhir SharmaManaging Director22 Jun 199432 Years 4 MonthsCurrent
Abhishek SharmaDirector20 Mar 20188 Years 8 MonthsCurrent

Auditor

Seamac India Pharmaceuticals Private Limited is audited by KASHYAP SIKDAR & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
KASHYAP SIKDAR & COFY 2019016253N

Shareholding

The shareholding of Seamac India Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Seamac India Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹52.2 Lakh
Satisfied charges
None
Breakdown by lending institutions
Others₹0.38 Cr
Hrryana Financial Corp.₹0.14 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Jun 2020100397338Others₹6.4 LakhOpen
21 Aug 199990035344Others₹32 LakhOpen
24 Nov 199490033311Hrryana Financial Corp.₹13.8 LakhOpen

To see the full charge records of Seamac India Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Seamac India Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Seamac India Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
02AAACS3400P1ZNHimachal PradeshActive10 Jul 2017

To see the full GST registrations and return filing status of Seamac India Pharmaceuticals Private Limited, buy the company report.

Recent activity

Seamac India Pharmaceuticals Private Limited has 3 board changes on record since 1994: 2 appointments and 1 cessation. The latest: Pushpa Pandit ceased to be Director on 21 Mar 2018.

AGM
Seamac India Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Seamac India Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others amounted to Rs. 6.40 Lakh with Charge ID 100397338 was registered on 10 Jun 2020.
Charges
A charge with Others of Rs. 32.00 Lakh registered on 21 Aug 1999 with Charge ID 90035344 was modified on 20 Dec 2019.
Ceased
Pushpa Pandit ceased to be Director.
Appointed
Abhishek Sharma was appointed as Director.
Charges
A charge with Others amounted to Rs. 32.00 Lakh with Charge ID 90035344 was registered on 21 Aug 1999.
Charges
A charge with Hrryana Financial Corp. amounted to Rs. 13.80 Lakh with Charge ID 90033311 was registered on 24 Nov 1994.
Appointed
Sudhir Sharma was appointed as Managing Director.
Incorporation
22 Jun 1994
Seamac India Pharmaceuticals Private Limited was registered on 22 Jun 1994 with Roc Delhi I & aged 32 years 5 months as per MCA records.

Frequently asked questions

Seamac India Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 June 1994 (32+ years old) and is registered under CIN U74899DL1994PTC059752.

Seamac India Pharmaceuticals has 2 current directors:

The latest financial statements of Seamac India Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Seamac India Pharmaceuticals is 02AAACS3400P1ZN, registered in Himachal Pradesh.

The CIN (Corporate Identification Number) of Seamac India Pharmaceuticals is U74899DL1994PTC059752. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Seamac India Pharmaceuticals was incorporated on 22 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.

Pushpa Pandit ceased to be Director on 21 Mar 2018. Abhishek Sharma was appointed as Director on 20 Mar 2018. Sudhir Sharma was appointed as Managing Director on 22 Jun 1994.

The registered office of Seamac India Pharmaceuticals is at D – 3 Lgf Lajpat Nagar, New Delhi, Delhi, India – 110024.

Seamac India Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Seamac India Pharmaceuticals has open charges of ₹52.2 Lakh and no satisfied charges on record as per latest MCA filings.